BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12254492)

  • 1. Haematocrit and other haematological values in women using intrauterine contraceptive device.
    Sharma SD; Singh G
    J Obstet Gynaecol India; 1970 Dec; 20(6):753-5. PubMed ID: 12254492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the coagulation and fibrinolytic systems in females using intrauterine contraceptive device.
    Sharma SD; Singh G
    J Obstet Gynaecol India; 1972 Feb; 22():57-9. PubMed ID: 12306050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of intrauterine contraceptive device.
    Dawn CS; Sinha S; Poddar DL
    J Obstet Gynaecol India; 1968 Apr; 18(2):252-6. PubMed ID: 12331814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of iron deficiency anemia in IUD users by prostaglandin synthetase inhibitors.
    Blum M; Pery J
    Contracept Deliv Syst; 1984 Jan; 5(1):21-3. PubMed ID: 12312741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical evaluation of intrauterine contraceptive devices.
    Mukherjee SN; Mukherjee S
    J Obstet Gynaecol India; 1968 Apr; 18(2):237-43. PubMed ID: 12156551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation studies in women using combination type of oral contraceptives.
    Sharma S; Sharma M; Soni IJ; Gupta A; Jain R
    J Obstet Gynaecol India; 1983 Aug; 33(4):519-24. PubMed ID: 12339832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some observations on intrauterine contraceptive device (Lippes loop).
    Menon MK
    J Obstet Gynaecol India; 1970 Jun; 20(3):289-97. PubMed ID: 12275251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of Lippes Loop and CuT inserted in immediate post-abortal period.
    Chowdhury NN; Mandal GS; Das M
    J Obstet Gynaecol India; 1979 Apr; 29(2):234-44. PubMed ID: 12156558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IUD insertion immediately after incomplete abortion.
    Goldsmith A; Goldberg R; Eyzaguirre H; Lizana L
    IPPF Med Bull; 1972 Apr; 6(2):1-2. PubMed ID: 12333065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IUD and anemia: a study of hematocrit.
    Fernandez XT; Young B; Lavin P; Baeza R; Seaman V
    Contracept Deliv Syst; 1980 Jan; 1(1):49-53. PubMed ID: 12261717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between two IUDs: Progestasert and CuT 200.
    Larsen S; Hansen MK; Jacobsen JC; Ladehoff P; Sorensen T; Westergaard JG
    Contracept Deliv Syst; 1981 Oct; 2(4):281-6. PubMed ID: 12336988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intrauterine contraception in women over 35-years old: comparison between copper and progesterone IUDs].
    Calzolari E; Galoppi P; Masala L; Parisi C; Iannucci D; Salmaggi P; Custo GM; Zichella L
    Patol Clin Ostet Ginecol; 1985; 13(1):49-56. PubMed ID: 12342024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematologic characteristics in IUD users.
    Nehra PC; Magyar DM
    Contracept Deliv Syst; 1982 Apr; 3(2):149-54. PubMed ID: 12338169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial reaction with long use of intrauterine contraceptive devices (7-9 years).
    Hefnawi F; Askalani AH; Hasseeb F; Issa A
    Egypt Popul Fam Plann Rev; 1974 Jun; 7(1):1-10. PubMed ID: 12257563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine contraceptive device-its success and failure.
    Kishore N; Gupta K; Tandon V
    J Obstet Gynaecol India; 1968 Apr; 18(2):221-6. PubMed ID: 12331811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the characteristics of acceptors of copper-T device: compared to other IUDs.
    Kohli BR; Goel OP; Roy S
    J Popul Res; 1976; 3(2):16-28. PubMed ID: 12259620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancies with intra-uterine contraceptive device in situ.
    Nahamanovici C; Eymery JP; Salvat J; Robert Y; Racinet C
    Contracept Fertil Sex (Paris); 1979 May; 7(5):341-7. PubMed ID: 12335901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avoidance of the dimensional incompatibility as the main reason for side effects in intrauterine contraception.
    Kurz KH
    Contracept Deliv Syst; 1981 Jan; 2(1):21-9. PubMed ID: 12278585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.